Monoclonal antibody, mAb 4C13, an effective detoxicant antibody against ricin poisoning. 2015

Na Dong, and Longlong Luo, and Junhua Wu, and Peiyuan Jia, and Qian Li, and Yuxia Wang, and Zhongcai Gao, and Hui Peng, and Ming Lv, and Chunqian Huang, and Jiannan Feng, and Hua Li, and Junjie Shan, and Gang Han, and Beifen Shen
Beijing Institute of Pharmacology and Toxicology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing 100850, China.

Ricin is a glycoprotein produced in castor seeds and consists of two polypeptide chains named Ricin Toxin A Chain (RTA) and Ricin Toxin B Chain (RTB), linked via a disulfide bridge. Due to its high toxicity, ricin is regarded as a high terrorist risk for the public. However, antibodies can play a pivotal role in neutralizing the toxin. In this research, the anti-toxicant effect of mAb 4C13, a monoclonal antibody (mAb) established using detoxicated ricin as the immunized antigen, was evaluated. Compared with mAb 4F2 and mAb 5G6, the effective mechanism of mAb 4C13 was analyzed by experiments relating to its cytotoxicity, epitope on ricin, binding kinetics with the toxin, its blockage on the protein synthesis inhibition induced by ricin and the intracelluar tracing of its complex with ricin. Our result indicated that mAb 4C13 could recognize and bind to RTA, RTB and exert its high affinity to the holotoxin. Both cytotoxicity and animal toxicity of ricin were well blocked by pre-incubating the toxin with mAb 4C13. By intravenous injection, mAb 4C13 could rescue the mouse intraperitoneally (ip) injected with a lethal dose of ricin (20μg/kg) even at 6h after the intoxication and its efficacy was dependent on its dosage. This research indicated that mAb 4C13 could be an excellent candidate for therapeutic antibodies. Its potent antitoxic efficiency was related to its recognition on the specific epitope with very high affinity and its blockage of protein synthesis inhibition in cytoplasm followed by cellular internalization with ricin.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011041 Poisoning A condition or physical state produced by the ingestion, injection, inhalation of or exposure to a deleterious agent. Poisonings
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000992 Antitoxins Antisera from immunized animals that is purified and used as a passive immunizing agent against specific BACTERIAL TOXINS. Antitoxin
D012276 Ricin A protein phytotoxin from the seeds of Ricinus communis, the castor oil plant. It agglutinates cells, is proteolytic, and causes lethal inflammation and hemorrhage if taken internally. Castor Bean Lectin,Lectin, Castor Bean,Lectin, Ricinus,Ricin Toxin,RCA 60,RCA60,Ricin A Chain,Ricin B Chain,Ricin D,Ricin I,Ricinus Toxin,A Chain, Ricin,B Chain, Ricin,Ricinus Lectin,Toxin, Ricin,Toxin, Ricinus
D016019 Survival Analysis A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function. Analysis, Survival,Analyses, Survival,Survival Analyses

Related Publications

Na Dong, and Longlong Luo, and Junhua Wu, and Peiyuan Jia, and Qian Li, and Yuxia Wang, and Zhongcai Gao, and Hui Peng, and Ming Lv, and Chunqian Huang, and Jiannan Feng, and Hua Li, and Junjie Shan, and Gang Han, and Beifen Shen
February 2022, Toxins,
Na Dong, and Longlong Luo, and Junhua Wu, and Peiyuan Jia, and Qian Li, and Yuxia Wang, and Zhongcai Gao, and Hui Peng, and Ming Lv, and Chunqian Huang, and Jiannan Feng, and Hua Li, and Junjie Shan, and Gang Han, and Beifen Shen
February 2020, Monoclonal antibodies in immunodiagnosis and immunotherapy,
Na Dong, and Longlong Luo, and Junhua Wu, and Peiyuan Jia, and Qian Li, and Yuxia Wang, and Zhongcai Gao, and Hui Peng, and Ming Lv, and Chunqian Huang, and Jiannan Feng, and Hua Li, and Junjie Shan, and Gang Han, and Beifen Shen
January 2002, Medical oncology (Northwood, London, England),
Na Dong, and Longlong Luo, and Junhua Wu, and Peiyuan Jia, and Qian Li, and Yuxia Wang, and Zhongcai Gao, and Hui Peng, and Ming Lv, and Chunqian Huang, and Jiannan Feng, and Hua Li, and Junjie Shan, and Gang Han, and Beifen Shen
January 2013, BioMed research international,
Na Dong, and Longlong Luo, and Junhua Wu, and Peiyuan Jia, and Qian Li, and Yuxia Wang, and Zhongcai Gao, and Hui Peng, and Ming Lv, and Chunqian Huang, and Jiannan Feng, and Hua Li, and Junjie Shan, and Gang Han, and Beifen Shen
November 1990, Oncology (Williston Park, N.Y.),
Na Dong, and Longlong Luo, and Junhua Wu, and Peiyuan Jia, and Qian Li, and Yuxia Wang, and Zhongcai Gao, and Hui Peng, and Ming Lv, and Chunqian Huang, and Jiannan Feng, and Hua Li, and Junjie Shan, and Gang Han, and Beifen Shen
June 2018, Monoclonal antibodies in immunodiagnosis and immunotherapy,
Na Dong, and Longlong Luo, and Junhua Wu, and Peiyuan Jia, and Qian Li, and Yuxia Wang, and Zhongcai Gao, and Hui Peng, and Ming Lv, and Chunqian Huang, and Jiannan Feng, and Hua Li, and Junjie Shan, and Gang Han, and Beifen Shen
May 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Na Dong, and Longlong Luo, and Junhua Wu, and Peiyuan Jia, and Qian Li, and Yuxia Wang, and Zhongcai Gao, and Hui Peng, and Ming Lv, and Chunqian Huang, and Jiannan Feng, and Hua Li, and Junjie Shan, and Gang Han, and Beifen Shen
October 2005, Hybridoma (2005),
Na Dong, and Longlong Luo, and Junhua Wu, and Peiyuan Jia, and Qian Li, and Yuxia Wang, and Zhongcai Gao, and Hui Peng, and Ming Lv, and Chunqian Huang, and Jiannan Feng, and Hua Li, and Junjie Shan, and Gang Han, and Beifen Shen
January 1987, Acta histochemica. Supplementband,
Na Dong, and Longlong Luo, and Junhua Wu, and Peiyuan Jia, and Qian Li, and Yuxia Wang, and Zhongcai Gao, and Hui Peng, and Ming Lv, and Chunqian Huang, and Jiannan Feng, and Hua Li, and Junjie Shan, and Gang Han, and Beifen Shen
February 1993, Immunological investigations,
Copied contents to your clipboard!